Clinical trial
A Phase 2 Study of Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With Central Nervous System Involvement
NCT05478993 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With Central Nervous System Involvement
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 12, 2022
- Completion date
- July 10, 2025
- Enrollment
- 21 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.